As other medication has had limited success in treating their condition, epileptic children’s parents demand authorities to legalize medicinal marijuana use to help their kids.
17 of the US states have approved since 2014 the use of marijuana-derived cannabidiol (CBD) in children, limiting the THC concentration (Tetrahydrocannabinol – part of the plant that produces the high effects): Utah, Wyoming, Wisconsin, Iowa, Missouri, Oklahoma, Texas, Louisiana, Mississippi, Alabama, Tennessee, Georgia, Florida, South Carolina, North Carolina, Kentucky and Virginia. Moreover, Florida, Georgia and Louisiana allow limited medical marijuana use for cancer treatment.
CBD is the non-psychoactive component of the marijuana plant that has been found to help in treating certain medical conditions and also minimize pain in metastatic cancer patients. Although this has not yet been scientifically proved, CBD treatments seemed to work where other medication failed.
As many parents believe medical cannabis is their last option for their children, marijuana-derived medication is not FDA-approved. Many families move to states where marijuana treatments are legal.
25 children participate in a clinical trial at Children’s Hospital of Philadelphia. They are receiving doses of Epidiolex, a purified CBD (but low in THC drug) created by London-based GW Pharmaceuticals. A more than 50% reduction in children’s seizures was reported.
More research to test the efficacy and safety of oral cannabis extracts for treatment of pediatric epilepsies is needed, as doctors can not ignore success stories. The FDA monitors these studies for a future possible approval, if clinical trials results will be eloquent.